Insmed INSM
NASDAQ INSM
$126.31 -0.37 (-0.29%)
As of: Sep 4, 2026 · 3:59 PM EDT

Insmed (INSM) Profit After Tax (2010 - 2026)

Insmed (INSM) posted quarterly Profit After Tax of -$1.5 million for Q1 2026, up 99.43% year-over-year from -$730574.3 in Q1 2025, and up 99.55% quarter-over-quarter from -$324.7 million in Q4 2025.

Analysis

Insmed (INSM) Profit After Tax (2010 - 2026) Analysis & Trends

Insmed's Profit After Tax history runs 17 years deep, the most recent figure standing at -$1.5 million for Q1 2026.

  • In Q1 2026, Profit After Tax rose 99.43% year-over-year to -$1.5 million; the TTM figure through Mar 2026 stood at -$693.6 million (up 31.65% YoY), while the FY2025 annual figure was -$1.3 billion, down 39.08% from the prior year.
  • Profit After Tax for Q1 2026 stood at -$1.5 million, up from -$324.7 million in the prior quarter.
  • The five-year high for Profit After Tax was $562.0 million in Q4 2023, with the low at -$370.0 million in Q3 2025.
  • The 5-year median for Profit After Tax is -$157.8 million (2022), against an average of -$123.1 million.
  • The sharpest annual moves came in 2022 and 2023: Profit After Tax tumbled 40517.9% in 2022, then jumped 456.22% in 2023.
  • Insmed's Profit After Tax stood at -$157.8 million in 2022, then surged by 456.22% to $562.0 million in 2023, then sank by 142.19% to -$237.1 million in 2024, then slumped by 36.97% to -$324.7 million in 2025, then jumped by 99.55% to -$1.5 million in 2026.
  • Business Quant data shows INSM's Profit After Tax at -$1.5 million in Q1 2026, -$324.7 million in Q4 2025, and -$370.0 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -782.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -644.37 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 237.01 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 164.49 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 81.49 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -16.62 Mn
10 Incyte 25.44 Bn 20.91 Bn 1.57 Bn 585.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -16.62 Mn
Mar 31, 2026 -165.02 Mn
Dec 31, 2025 -328.50 Mn
Sep 30, 2025 -370.02 Mn
Jun 30, 2025 -321.69 Mn
Mar 31, 2025 -256.58 Mn
Dec 31, 2024 -237.09 Mn
Sep 30, 2024 -220.52 Mn
Jun 30, 2024 -301.80 Mn
Mar 31, 2024 -157.98 Mn
Dec 31, 2023 -184.73 Mn
Sep 30, 2023 -159.76 Mn
Jun 30, 2023 -247.14 Mn
Mar 31, 2023 -159.76 Mn
Dec 31, 2022 -157.98 Mn
Sep 30, 2022 -131.60 Mn
Jun 30, 2022 -96.34 Mn
Mar 31, 2022 -95.82 Mn
Dec 31, 2021 -112.89 Mn
Sep 30, 2021 -113.04 Mn